• Adeline Y Lukmantara, Danuta S Kalinowski, Naresh Kumar, and Des R Richardson.
• School of Chemistry, University of New South Wales, Sydney, NSW 2052, Australia. Electronic address: adeline.lukmantara@gmail.com.
• J. Inorg. Biochem. 2014 Dec 1; 141: 43-54.

AbstractThiosemicarbazone chelators represent an exciting class of biologically active compounds that show great potential as anti-tumor agents. Our previous studies demonstrated the potent anti-tumor activity of the 2'-benzoylpyridine thiosemicarbazone series. While extensive studies have been performed on monomeric thiosemicarbazone compounds, dimeric thiosemicarbazone chelators have received comparatively less attention. Thus, it was of interest to investigate the anti-proliferative activity and iron chelation efficacy of dimeric thiosemicarbazones. Two classes of dimeric thiosemicarbazones were designed and synthesized. The first class consisted of two benzoylpyridine-based thiosemicarbazone units connected via a hexane or dodecane alkyl bridge, while the second class of dimer consisted of two thiosemicarbazones attached to a 2,6-dibenzoylpyridine core. These dimeric ligands demonstrated greater anti-proliferative activity than the clinically used iron chelator, desferrioxamine. This study highlights the importance of optimal lipophilicity as a factor influencing the cytotoxicity and iron chelation efficacy of these chelators. Copyright © 2014 Elsevier Inc. All rights reserved.

30 keywords...

hide…